Literature DB >> 8730587

Activation and blockade of mouse muscle nicotinic channels by antibodies directed against the binding site of the acetylcholine receptor.

J Bufler1, S Kahlert, S Tzartos, K V Toyka, A Maelicke, C Franke.   

Abstract

1. Using the patch-clamp technique, we have found that mouse muscle nicotinic acetylcholine receptor (nAChR) channels can be activated by low concentrations of a monoclonal antibody (MoAb), referred to as WF6, which is directed against the acetylcholine (ACh) binding site. Similar effects were seen using IgG or F(ab)2 fragments from the sera of patients with myasthenia gravis (MG), which contain polyclonal anti-nAChR antibodies. 2. The mean open times of MoAb and the slope conductance of single WF6-activated single channels were similar to those of ACh-activated channels under the same experimental conditions. 3. On outside-out patches, single channel activity was elicited by MoAb WF6 and MG F(ab)2 fragments, and was blocked by (+)-tubocurarine. We therefore concluded that MoAb WF6 and the MG F(ab)2 fragments activate the nAChR. 4. MoAb WF6 and MG F(ab)2 fragments blocked the current activated by pulsed application of 10(-4) M ACh to a significant extent. The block was partly reversible. The rate constants for the binding and dissociation of MoAb WF6 from the receptor were determined quantitatively.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8730587      PMCID: PMC1158865          DOI: 10.1113/jphysiol.1996.sp021293

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  23 in total

1.  Effector mechanisms in myasthenia gravis: end-plate function after passive transfer of IgG, Fab, and F(ab')2 hybrid molecules.

Authors:  R Sterz; R Hohlfeld; K Rajki; M Kaul; K Heininger; K Peper; K V Toyka
Journal:  Muscle Nerve       Date:  1986-05       Impact factor: 3.217

2.  Organization of ligand binding sites at the acetylcholine receptor: a study with monoclonal antibodies.

Authors:  D Watters; A Maelicke
Journal:  Biochemistry       Date:  1983-04-12       Impact factor: 3.162

3.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

4.  Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG.

Authors:  K V Toyka; B Löwenadler; K Heininger; U A Besinger; K L Birnberger; A Fateh-Moghadam; E Heilbronn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-09       Impact factor: 10.154

5.  Monoclonal antibodies modify acetylcholine-induced ionic channel properties in cultured chick myoballs.

Authors:  G Goldberg; D Mochly-Rosen; S Fuchs; Y Lass
Journal:  J Membr Biol       Date:  1983       Impact factor: 1.843

6.  Fluorescein isothiocyanate-labeled alpha-cobratoxin. Biochemical characterization and interaction with acetylcholine receptor from Electrophorus electricus.

Authors:  S Kang; A Maelicke
Journal:  J Biol Chem       Date:  1980-08-10       Impact factor: 5.157

7.  Myasthenia gravis: passive transfer from man to mouse.

Authors:  K V Toyka; D B Brachman; A Pestronk; I Kao
Journal:  Science       Date:  1975-10-24       Impact factor: 47.728

8.  Cross-reactivity of anti-acetylcholine receptor autoantibodies.

Authors:  M J Garlepp; P H Kay; R L Dawkins; R C Bucknall; A Kemp
Journal:  Muscle Nerve       Date:  1981 Jul-Aug       Impact factor: 3.217

9.  Fast events in single-channel currents activated by acetylcholine and its analogues at the frog muscle end-plate.

Authors:  D Colquhoun; B Sakmann
Journal:  J Physiol       Date:  1985-12       Impact factor: 5.182

10.  Precise epitope mapping of monoclonal antibodies to the cytoplasmic side of the acetylcholine receptor alpha subunit. Dissecting a potentially myasthenogenic epitope.

Authors:  S J Tzartos; M S Remoundos
Journal:  Eur J Biochem       Date:  1992-08-01
View more
  7 in total

1.  Identification of the Kv2.1 K+ channel as a major component of the delayed rectifier K+ current in rat hippocampal neurons.

Authors:  H Murakoshi; J S Trimmer
Journal:  J Neurosci       Date:  1999-03-01       Impact factor: 6.167

2.  Progress in the treatment of myasthenia gravis.

Authors:  Ralf Gold; Reinhard Hohlfeld; Klaus V Toyka
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

3.  Activation of heteroliganded mouse muscle nicotinic receptors.

Authors:  Gustav Akk; Lorin S Milescu; Manfred Heckmann
Journal:  J Physiol       Date:  2005-02-17       Impact factor: 5.182

4.  Effect of sera from seronegative myasthenia gravis patients on neuromuscular junctions.

Authors:  Rumi Sato; Shiho Imamoto; Iku Utsnomiya; Terumasa Chiba; Kyoji Taguchi; Kenji Abe; Keiko Tanaka; Tadashi Miyatake
Journal:  Neurol Sci       Date:  2013-02-07       Impact factor: 3.307

5.  Neuronal MHC class I molecules are involved in excitatory synaptic transmission at the hippocampal mossy fiber synapses of marmoset monkeys.

Authors:  Adema Ribic; Mingyue Zhang; Christina Schlumbohm; Kerstin Mätz-Rensing; Barbara Uchanska-Ziegler; Gabriele Flügge; Weiqi Zhang; Lutz Walter; Eberhard Fuchs
Journal:  Cell Mol Neurobiol       Date:  2010-03-16       Impact factor: 5.046

Review 6.  Current and future standards in treatment of myasthenia gravis.

Authors:  Ralf Gold; Christiane Schneider-Gold
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

7.  Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs.

Authors:  Hakan Cetin; Richard Webster; Wei Wei Liu; Akiko Nagaishi; Inga Koneczny; Fritz Zimprich; Susan Maxwell; Judith Cossins; David Beeson; Angela Vincent
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-03-12       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.